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MY THOUGHTS AND REFLECTIONS ON THE TENTH ANNIVERSARY OF
THE 2008 FINANCIAL CRISIS AND OTHER CURRENT MATTERS
BY PROFESSOR RONALD FILLER
It seems like just yesterday that we were all expressing our thoughts and
reflections on the 5th anniversary of the Dodd-Frank Act (“DFA”) for the
FDLR. Yet, now, some three years later, to be honest, not much more has
changed. We really still do not know at this time, its true impact and
whether Messrs. Dodd and Frank did the right thing then or not.
One policy change has occurred. President Trump issued an Executive
Order early in his presidency that required all agencies, including the
CFTC, to re-evaluate all of its regulations and make changes where
needed to make it easier and less costly to comply with them. We have
seen proposed changes to the Volcker Rule and some other minor
legislative changes but I doubt if Title VII of the DFA will change in any
material way over the next several years. I am not saying such legislative
changes are not needed, they are, but that Title VII carries little to no
political weight or interest.
However, with respect to regulatory changes at the CFTC, that exercise is
still a work in progress. More importantly, ten years after DFA, we still
await what the net capital requirements are for swap dealers. That
should have been the very first regulation right after the registration
requirements were adopted in 2011. Today, there are approximately 104
swap dealers and that number has remained fairly constant over the past
several years but all are still provisionally registered. Amazing!!
I note the two Executive Orders issued by President Trump in 2017
regarding the financial markets and how regulatory reforms should
occur. As to what legislative and regulatory changes should not occur, I
am still a big believer in how OTC clearing can and does reduce systemic
risks. Therefore, I supported then, and still do today, the mandatory
clearing requirement imposed on OTC derivatives under Title VII.
Obviously, such a belief depends on clearinghouses setting the proper
initial performance risk levels and in providing the requisite financial
resources to ensure their financial integrity. Having served on several
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CCP Boards and CCP Risk Advisory Committees during my 35+ years in
this great industry, I really do believe that the CCPs will always do the
right thing, I also do hope that I will never be proven to be wrong on this
belief.
I was formerly a critic in the way the CFTC had initially administered its
duties and obligations following the passage of Dodd-Frank. While I
strongly applaud and admire its success in adopting the 60+ regulations
required by the DFA, I did not agree at all with the process the CFTC had
applied. New and highly complex regulations were hastily enacted, many
with as little as 60 days’ notice of their effective date. Such haste has
resulted in the issuance of hundreds of no-action letters, some just hours
before the effective date, on so many of them. My views have changed
dramatically on this issue. I commend Chair Giancarlo on making great
progress and focusing on key issues. His two major white papers have
provided important insight as to how and what the CFTC needs to focus
on now and over the next few years.
Moreover, whatever happened to the global harmonized approach that
all G-20 countries agreed to in September 2009 in Pittsburgh? Granted,
everyone else outside the US took a slower, some would argue a more
considered, path and therefore missed the December 2012 deadline
agreed to in Pittsburgh. And, yes, some countries still have not taken any
action. So what? OTC derivatives are a global business. All of the top 15
firms in this business have offices and affiliates around the globe. Many
are major non-US banks with affiliates in the US. The DFA anticipated a
better risk management approach to ensure, to the extent possible, that
we would never have another major bank failure, and, more importantly,
never ever require another bailout. The legislation specifically
recognized the need for a greater harmonized regulatory approach
relating to OTC derivatives and gave the regulators great latitude in
designing the operating framework. The worse thing to occur, and it has
occurred, is the infighting between Europe and the US and the contest
about whose regime will be triumphant. Harmonization is not about
winning. It’s called sharing. It’s also called comparability within proper
parameters. Hopefully, the CFTC and the European Commission will
realize the need to agree to share and accept comparability between the
US and EU.
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I know that the CFTC has recently confirmed the de minimus amount of
$8 billion for determining whether a swap dealer needs to be registered.
A swap dealer with notional amounts of swaps of $8 billion will not have
any impact on the swaps markets if that firm failed. Finally, can someone
please explain to me how $7.999 billion of trading of OTC derivatives is
de minimis and does not require that swap dealer to register with the
CFTC whereas $8.0 billion qualifies as having a “direct and significant
effect on the U.S. economy” as required by Section 721. It’s a direct and
significant test, not either one. I grew up in a small country town in NW
Tennessee so I guess my math background is not as sophisticated as those
who live in Washington but I always thought that the U.S. economy is
quite large. This must have simply been a typographical error as the
CFTC probably meant to add 2-3 zeros to the end of that $8.0 billion
number.
I have now spent 35+ years in this great industry. I have been truly
blessed and honored to know some very great and wonderful people. I
have taught a law school course on the CEA and CFTC and industry
regulations, customs and practices since 1977, first at the Chicago Kent
College of Law, then later at Brooklyn Law School, the University of
Illinois College of Law and now at New York Law School. It was called
Commodities Law in 1977 but has been renamed as Derivatives Law just
to show others that I can adjust. I have co-authored a treatise on
Derivatives Law with my good friend, Prof. Jerry Markham. In fact, that
was a dream that I had for over 35 years. I speak each year all over the
globe on current legislative and regulatory policies and publish several
papers each year. Finally, I do not know an actual number but I’m
guessing that over 150 of my former law students now work in this great
industry. I call them “Filler’s Army” and that army is still growing each
and every year. You see, I have been truly blessed. That’s the real truth.
Professor Ronald Filler
New York Law School
© Ronald Filler
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